(Press-News.org) The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells can acquire the ability to evade apoptosis and become more resistant to therapy. Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have now obtained results from the first tests using a new substance that can restore the function of defective p53 and activate apoptosis in cancer cells.
The substance is known as APR-246 and has now been tested on humans in a phase I/II study, which was conducted on 22 patients with advanced blood or prostate cancer. Some of the patients came from the Haematology Centre at the Karolinska University Hospital in, Stockholm, where the study's lead investigator, consultant Dr Sören Lehmann is based. The remainder of the patients were from other clinics in Gothenburg, Lund, Uppsala and Örebro.
The patients received daily infusions of APR-246 for four days. When the researchers analyzed the cancer cells taken before and after treatment, they saw indications that the p53 gene had been activated to varying degrees, and that this had triggered the suicide program in the cancer cells. Ten patients could be evaluated as regards the development of their cancer, and in two of them there were signs of tumour regression.
However, the study was actually not designed to test the clinical effects but to ascertain how well the substance was tolerated by the body. With the main adverse reactions confined to temporary tiredness, nausea, headache and confusion, their results would suggest that the substance is well tolerated.
"The side-effects were totally different to those produced by conventional chemotherapy, which bodes well for designing combination therapies," says Dr Lehmann. "And it's in precisely this kind of combination that we think the substance has the greatest potential. In previous laboratory studies we've seen that APR-246 has generated synergy gains when used with chemotherapy due to the mutually enhancing effects of both substances."
Defective p53 is considered one of the most common factors behind the development of cancer. In some cancers, such as ovarian cancer, the vast majority of tumours have defective p53. In total, the p53 tumour suppressor gene is mutated in at least half of all tumours.
"In theory, a drug that restores p53 function should be effective against many different kinds of cancer, provided that the individual tumour contains defective p53," says study team member Professor Klas Wiman. "We should keep in mind, however, that tumours are very complex."
APR-246 was discovered by Klas Wiman and colleagues at Karolinska Institutet, and the present study was led from Karolinska University Hospital in association with Aprea AB. Aprea AB's principal shareholder is Karolinska Development, a company listed on the NASDAQ OMX Stockholm exchange. Professor Wiman is co-founder and shareholder of Aprea, and a member of its board.
###
Publication: 'Targeting p53 in vivo: A first-in-man study with the p53-targeting compound APR-246 (PRIMA-1MET) in refractory hematological malignancies and prostate cancer', Sören Lehmann, Vladimir J.N. Bykov, Dina Ali, Ove Andrén, Honar Cherif, Ulf Tidefelt, Bertil Uggla, Jeffrey Yachnin, Gunnar Juliusson, Ali Moshfegh, Christer Paul, Klas G. Wiman and Per-Ola Andersson, Journal of Clinical Oncology, early online publication 10 September 2012, doi: 10.1200/JCO.2011.40.7783.
For further information, please contact:
Sören Lehmann, MD, PhD, Principal Investigator
Centre for Haematology and Regenerative Medicine (HERM), Karolinska Institutet
Haematology Centre, Karolinska University Hospital
Tel: +46 (0)8-58582677 or +46 (0)70-7604882
Email: soren.lehmann@ki.se
Klas G. Wiman, MD, PhD, Professor
Department of Oncology-Pathology, Karolinska Institutet
Tel: +46 (0)8-51779342 or +46 (0)73-9866586
Email: klas.wiman@ki.se
Contact the Press Office and download photos: ki.se/pressroom
Karolinska Institutet is one of the world's leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country's broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Hopes that new substance will induce cancer cell suicide
2012-09-18
ELSE PRESS RELEASES FROM THIS DATE:
Bariatric surgery substantially reduces the risk of diabetes
2012-09-18
Bariatric surgery reduces the long-term risk of developing diabetes by over 80 % among people with obesity. The New England Journal of Medicine (NEJM) has published the results of a study conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.
A study conducted by Professor Lars Sjöström, Professor Lena Carlsson and their team at Sahlgrenska Academy, University of Gothenburg, has found that bariatric surgery is considerably more effective than traditional care and lifestyle changes in preventing diabetes among people with obesity.
The treatment group consisted ...
How Swedes feel about health, culture and recycling of clothes
2012-09-18
Our values change as we age. This is the main conclusion of the 2011 SOM survey, from the University of Gothenburg, Sweden, where Swedes were asked to rate the importance of different values. Young people want their lives to be exciting, whereas the older prioritise national security. Cultural life does not promote physical health, but does affect a person's perceived well-being. Three Swedes in five throw away clothes that are in usable condition.
'Our most interesting finding is that people born in the 1960s and 1970s seem to be adopting the values of their parents' ...
Who is entitled to social welfare?
2012-09-18
A Danish researcher has compared two of the most different welfare systems in the western world. Despite the differences, the research shows surprising similarities in the way in which people in the USA and Denmark perceive the deservingness of welfare recipients.
This is one of the conclusions presented in a research article by the highly recognised American Journal of Political Science.
- The question of whether a person deserves help or not triggers a number of deep psychological processes. No matter where we come from, whether we are right or left-wing - it is ...
New findings on protein misfolding
2012-09-18
Misfolded proteins can cause various neurodegenerative diseases such as spinocerebellar ataxias (SCAs) or Huntington's disease, which are characterized by a progressive loss of neurons in the brain. Researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, together with their colleagues of the Université Paris Diderot, Paris, France, have now identified 21 proteins that specifically bind to a protein called ataxin-1. Twelve of these proteins enhance the misfolding of ataxin-1 and thus promote the formation of harmful protein aggregate structures, ...
New gene offers hope for preventive medicine against fractures
2012-09-18
A big international study has identified a special gene that regulates bone density and bone strength. The gene can be used as a risk marker for fractures and opens up opportunities for preventive medicine against fractures. The study, led by the Sahlgrenska Academy, University of Gothenburg, Sweden, was published in the journal PLoS Genetics.
The international study, which involved more than 50 researchers from Europe, North America and Australia and was led by Associate Professor Mattias Lorentzon and Professor Claes Ohlsson at the Sahlgrenska Academy, University of ...
Do you want to know another role of ribonucleotide reductase M2?
2012-09-18
Colorectal cancer (CRC) is the leading cause of cancer-related death worldwide. In addition, the incidence and mortality rates of colorectal cancer are on the rise. Recently, metabolic genes have received increasing and specific attention due to their potential role in carcinogenesis. Previous studies have shown that alterations in ribonucleotide reductase (RR) levels may significantly influence the biological properties of cells, including tumor promotion and tumor progression, suggesting that RR may be implicated in tumorigenesis. Recent findings have established that ...
Research study on the location of the Island of Stability of Super-Heavy Elements
2012-09-18
An international research group – with the participation of the University of Granada – has achieved to measure the effects of layers on super-heavy elements, which provides useful data on the nuclear structure of these as-yet undiscovered elements in Nature. These results might be useful to locate the so-called "Island of Stability" introduced by a theory that states the existence of highly stable super-heavy elements with very long average lives. The researchers measured the isotopes of nobelium and lawrence using a particle accelerator at the Center of for Heavy Ion ...
Tasered youth fare as well as adults, new research says
2012-09-18
WINSTON-SALEM, N.C. – Sept. 18, 2012 -- Adolescents who are tasered by law enforcement officers do not appear to be at higher risk for serious injury than adults, according to new a new study from Wake Forest Baptist Medical Center researchers.
This latest research from Wake Forest Baptist is the first to specifically investigate Taser use on adolescents. Lead author Alison R. Gardner, M.D., an assistant professor of emergency medicine at Wake Forest Baptist, found no major differences in the injury rates or types of injuries to youth when compared to adults.
"We were ...
Consumers differ in desire for explanation, says new CU-Brown University study
2012-09-18
The depth of explanation about novel products influences consumer preferences and willingness to pay, according to a study led by the University of Colorado Boulder and Brown University.
When it comes to descriptions about the functions of new and unusual goods -- such as a self-watering plant system, special gloves for touchscreens or an eraser for wall scratches -- some people prefer minimal details. Dubbed "explanation foes" in the study, they gain a strong sense of understanding and desire for products through shallow explanations.
In contrast, other people -- dubbed ...
NRL demonstrates high durability of nanotube transistors to the harsh space environment
2012-09-18
WASHINGTON--U.S. Naval Research Laboratory electronics science and technology engineers demonstrate the ability of single walled carbon nanotube transistors (SWCNTs) to survive the harsh space environment, investigating the effects of ionizing radiation on the crystalline structures and further supporting the development of SWCNT-based nanoelectronics for use in harsh radiation environments.
"One of the primary challenges for space electronics is mitigating the susceptibility of prolonged exposure to radiation that exists in the charged particle belts that encircle Earth," ...